Jose Derraik
University of Auckland
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jose Derraik.
Diabetes Care | 2010
Paul Hofman; Jose Derraik; Teresa E. Pinto; Sheryl Tregurtha; Ann Faherty; Jane M Peart; Paul L. Drury; Elizabeth Robinson; Ramin Tehranchi; Morten Donsmark; Wayne S. Cutfield
OBJECTIVE We aimed to establish the ideal injection techniques using 5-mm needles to reliably inject insulin into the subcutaneous fat in both children and adults and to quantify the associated pain and leakage of the test medium. RESEARCH DESIGN AND METHODS A total of 259 subjects (122 children/adolescents and 137 adults) were injected with sterile air corresponding to 20 IU insulin (200 μl) with 32-G 5-mm needles at 90° or 45°, in the abdomen and thigh, and with or without a pinched skin fold. Injection depth was assessed via ultrasonography. Subjects rated pain on a visual analog scale. Test medium injections into the abdomen and thigh (0.2–0.6 ml) were also administered to assess injection leakage. RESULTS Among children, 5.5% of injections were intramuscular (IM) and 0.5% were intradermal, while in adults, the incidence was 1.3 and 0.6%, respectively. The frequency of IM injections was greater in boys and negligible among adult women. Subcutaneous fat thickness was the primary predictor of the likelihood of IM injections (P < 0.001). A third of all patients reported experiencing no pain during insulin injection, with children/adolescents experiencing considerably more discomfort than adults. Some leakage of medium was observed, but was unrelated to injection volume and was generally minimal. CONCLUSIONS 5-mm needles are reliably inserted into subcutaneous fat in both adults and children. These needles were associated with reduced pain and minimal leakage. We recommend an angled injection with a pinched skin fold for children, while in adults, the technique should be left to patient preference.
PLOS ONE | 2013
Ahila Ayyavoo; Jose Derraik; Paul Hofman; Sarah Mathai; Janene B. Biggs; Peter Stone; Lynn C. Sadler; Wayne S. Cutfield
Background There are no data on the metabolic consequences of post-term birth (≥42 weeks gestation). We hypothesized that post-term birth would adversely affect insulin sensitivity, as well as other metabolic parameters and body composition in childhood. Methods 77 healthy pre-pubertal children, born appropriate-for-gestational-age were studied in Auckland, New Zealand: 36 born post-term (18 boys) and 41 (27 boys) born at term (38–40 weeks gestation). Primary outcome was insulin sensitivity measured using intravenous glucose tolerance tests and Bergman’s minimal model. Other assessments included fasting hormone concentrations and lipid profiles, body composition from whole-body dual-energy X-ray absorptiometry, 24-hour ambulatory blood pressure monitoring, and inflammatory markers. Results Insulin sensitivity was 34% lower in post-term than in term children (7.7 vs. 11.6 x10-4·min-1·(mU/l); p<0.0001). There was a compensatory increase in acute insulin response among post-term children (418 vs 304 mU/l; p=0.037), who also displayed lower glucose effectiveness than those born at term (2.25 vs 3.11 x10-2·min-1; p=0.047). Post-term children not only had more body fat (p=0.014) and less fat-free mass (p=0.014), but also had increased central adiposity with more truncal fat (p=0.017) and greater android to gynoid fat ratio (p=0.007) compared to term controls. Further, post-term children displayed other markers of the metabolic syndrome: lower normal nocturnal systolic blood pressure dipping (p=0.027), lower adiponectin concentrations (p=0.005), as well as higher leptin (p=0.008) and uric acid (p=0.033) concentrations. Post-term boys (but not girls) also displayed a less favourable lipid profile, with higher total cholesterol (p=0.018) and LDL-C (p=0.006) concentrations, and total cholesterol to HDL-C ratio (p=0.048). Conclusions Post-term children have reduced insulin sensitivity and display a number of early markers of the metabolic syndrome. These findings could have important implications for the management of prolonged pregnancies. Future studies need to examine potential impacts later in life, as well as possible underlying mechanisms.
International Journal of Pediatric Endocrinology | 2013
Samuel W. Cutfield; Jose Derraik; Craig Jefferies; Paul Hofman; Wayne S. Cutfield
Methods Data from Auckland children with newly diagnosed T1DM between 1 January 2000 and 31 December 2009 were collected from Starbase, the Starship Children’s Hospital diabetes database. T1DM was confirmed by the presence of glutamic acid decarboxylase and/or tyrosime phosphatise-like protein (IA2) antibodies. DKA was defined by international criteria as venous or capillary pH and bicarbonate as mild DKA with pH <7.30 and bicarbonate <15 mmol/l, moderate DKA pH <7.20 and bicarbonate <10 mmol/l and severe DKA ph <7.10 and bicarbonate <5 mmol/l.
55th Annual ESPE | 2016
Valentina Chiavaroli; Sarah A. Hopkins; Jose Derraik; Sumudu N. Seneviratne; Janene B. Biggs; Raquel Rodrigues; Wayne Cutfield; Paul Hofman
55th Annual ESPE | 2016
Valentina Chiavaroli; Thilini N. Jayasinghe; Cameron Ekblad; Jose Derraik; Paul Hofman; Wayne Cutfield
54th Annual ESPE | 2015
Wayne Cutfield; Anders Lindberg; Paul Hofman; Jose Derraik; Mitchell E. Geffner; Cecilia Camacho-Hübner
54th Annual ESPE | 2015
Silmara Gusso; Patrícia Colle; Jose Derraik; Janene B. Biggs; Craig Munns; Wayne Cutfield; Paul Hofman
Obesity Research & Clinical Practice | 2012
M. de Bock; Jose Derraik; Christine M. Brennan; Janene B. Biggs; Greg C. Smith; David Cameron-Smith; Clare Wall; Wayne S. Cutfield
Obesity Research & Clinical Practice | 2012
Ahila Ayyavoo; Paul Hofman; Jose Derraik; S. Mathia; Janene B. Biggs; Peter Stone; L. Sadler; Wayne S. Cutfield
Obesity Research & Clinical Practice | 2012
Paul Hofman; Wayne S. Cutfield; Jose Derraik; Sarah Mathai; Stuart R Dalziel; Jane E. Harding; Craig Jefferies